SHREE GANESH REMEDIES   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
SHREE GANESH REMEDIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| CEPS(Rs) | 25.42 | 26.64 | 10.56 | 6.01 | 
What is the latest Cash Earnings per Share (CEPS) ratio of SHREE GANESH REMEDIES ?
| Year | Cash Earnings per Share (CEPS) | 
|---|---|
| Mar2025 | 25.42 | 
| Mar2024 | 26.64 | 
| Mar2020 | 10.56 | 
| Mar2019 | 6.01 | 
How is Cash Earnings per Share (CEPS) of SHREE GANESH REMEDIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 25.42 | -4.58 | |
| Mar2024 | 26.64 | 152.27 | |
| Mar2020 | 10.56 | 75.71 | |
| Mar2019 | 6.01 | - | |
Other Financial Ratios of SHREE GANESH REMEDIES
| Operational &  Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Cash Earnings per Share (CEPS) ratio of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹627.8 Cr | -0.1% | -6.6% | -35.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| SHREE GANESH REMEDIES |    -0.1%  | 
                            
                     
                     -6.6%  | 
                     
                     -35.5%  | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses